Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
FIVE PRIME THERAPEUTICS, INC. (FPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2021 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 2,385 shares
@ $0
Gifted 795 shares
@ $0
Gifted 1,440 shares
@ $0
Gifted 2,460 shares
@ $0
Gifted 14,174 shares
@ $0
Granted 66,000 shares
@ $0
Disposed/sold 169,468 shares
@ $38, valued at
$6.4M
Disposed/sold 795 shares
@ $38, valued at
$30.2k
Disposed/sold 4,747 options to buy
@ $8.49, valued at
$40.3k
Disposed/sold 9,142 options to buy
@ $5.54, valued at
$50.6k
Disposed/sold 12,063 options to buy
@ $7.26, valued at
$87.6k
|
|
| 04/19/2021 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 66,000 shares
@ $0
Disposed/sold 138,947 shares
@ $38, valued at
$5.3M
Disposed/sold 185,000 options to buy
@ $12.47, valued at
$2.3M
Disposed/sold 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 04/19/2021 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 8,085 shares
@ $0
Granted 66,000 shares
@ $0
Disposed/sold 135,547 shares
@ $38, valued at
$5.2M
Disposed/sold 60,000 options to buy
@ $37.89, valued at
$2.3M
Disposed/sold 50,000 options to buy
@ $18.69, valued at
$934.5k
Disposed/sold 58,000 options to buy
@ $11.97, valued at
$694.3k
Disposed/sold 20,000 options to buy
@ $5.78, valued at
$115.6k
Disposed/sold 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 04/19/2021 |
4
| White David (See Remarks) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 33,423 shares
@ $38, valued at
$1.3M
Disposed/sold 30,000 options to buy
@ $11.58, valued at
$347.4k
Disposed/sold 25,000 options to buy
@ $5.25, valued at
$131.3k
|
|
| 04/19/2021 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 10,000 shares
@ $0
Disposed/sold 16,600 options to buy
@ $11.65, valued at
$193.4k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 34,451 options to buy
@ $3.79, valued at
$130.6k
Disposed/sold 46,939 options to buy
@ $3.99, valued at
$187.3k
Disposed/sold 50,367 options to buy
@ $3.23, valued at
$162.7k
Disposed/sold 49,552 options to buy
@ $3.94, valued at
$195.2k
Disposed/sold 40,868 options to buy
@ $5.31, valued at
$217k
|
|
| 04/19/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 5,000 shares
@ $38, valued at
$190k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $37.99, valued at
$949.8k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Jensen Peder (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 12,500 options to buy
@ $12.7, valued at
$158.8k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Nicholson Garry A (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 15,000 options to buy
@ $29.8, valued at
$447k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $9.17, valued at
$229.3k
Disposed/sold 1,250 options to buy
@ $6.09, valued at
$7.6k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $6.3, valued at
$157.5k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 68,971 shares
@ $38, valued at
$2.6M
Disposed/sold 480,000 options to buy
@ $2.72, valued at
$1.3M
|
|
| 04/13/2021 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,088 shares
@ $37.94, valued at
$420.7k
|
|
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,158 shares
@ $22.23, valued at
$25.7k
|
|
| 03/02/2021 |
4
| White David (See Remarks) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,461 shares
@ $22.23, valued at
$32.5k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 5,091 shares
@ $25.71, valued at
$130.9k
Paid exercise price by delivering 1,653 shares
@ $23.08, valued at
$38.2k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| White David (See Remarks) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,155 shares
@ $25.71, valued at
$29.7k
|
|
| 12/15/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,583 shares
@ $16.14, valued at
$186.9k
Exercised 22,000 options to buy
@ $0 |
|
| 12/15/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,504 shares
@ $16.14, valued at
$185.7k
Exercised 22,000 options to buy
@ $0 |
|
| 12/15/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,583 shares
@ $16.14, valued at
$186.9k
Exercised 22,000 options to buy
@ $0 |
|
| 11/30/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 6,920 shares
@ $18.45, valued at
$127.7k
|
|
| 11/13/2020 |
4
| BVF PARTNERS L P/IL (See Explanaton of Responses) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Sold 3,941,214 shares
@ $20.1867, valued at
$79.6M
Sold 2,949,477 shares
@ $20.1867, valued at
$59.5M
Sold 502,649 shares
@ $20.1867, valued at
$10.1M
|
|
| 11/13/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,001 shares
@ $18, valued at
$198k
Exercised 22,000 options to buy
@ $0 |
|
| 11/13/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,908 shares
@ $18, valued at
$196.3k
Exercised 22,000 options to buy
@ $0 |
|
| 11/13/2020 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,039 shares
@ $18, valued at
$198.7k
Exercised 22,000 options to buy
@ $0 |
|
| 11/13/2020 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Sold 52,959 shares
@ $22.5, valued at
$1.2M
Sold 26,000 shares
@ $22.5, valued at
$585k
Exercised 52,959 options to buy
@ $2.22, valued at
$117.6k
Exercised 26,000 options to buy
@ $2.8, valued at
$72.8k
|
|
| 11/06/2020 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Bought 257,804 shares
@ $4.8842, valued at
$1.3M
Bought 17,230 shares
@ $4.984, valued at
$85.9k
Bought 143,403 shares
@ $4.8842, valued at
$700.4k
Bought 10,436 shares
@ $4.984, valued at
$52k
Bought 15,355 shares
@ $4.8842, valued at
$75k
Bought 2,334 shares
@ $4.984, valued at
$11.6k
|
|
| 10/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|